NCT00963469View on ClinicalTrials.gov

Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,079

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

November 30, 2001

Study Completion Date

November 30, 2001

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

montelukast sodium

montelukast 10 mg tablet orally once daily in the morning for 4 weeks

DRUG

Comparator: loratadine

loratadine 10 mg tablet orally once daily in the morning for 4 weeks

DRUG

Comparator: placebo

placebo tablet orally once daily in the morning for 4 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00963469 - Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240) | Biotech Hunter | Biotech Hunter